Evidence map›Paper›PMID 28605664›Full record

ArticleThe Journal of nutritional biochemistry2017

Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats.

Matthew R Panasevich, Colin M Schuster, Kathryn E Phillips, Grace M Meers, Sree V Chintapalli, Umesh D Wankhade, Kartik Shankar, Dustie N Butteiger, Elaine S Krul, John P Thyfault and 1 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Journal of nutritional biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Matthew R PanasevichDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, USA; Harry S Truman Memorial VA Hospital, Columbia, MO, USA.
Colin M SchusterHarry S Truman Memorial VA Hospital, Columbia, MO, USA; Department of Medicine-Gastroenterology and Hepatology, Columbia, MO, USA.
Kathryn E PhillipsHarry S Truman Memorial VA Hospital, Columbia, MO, USA.
Grace M MeersHarry S Truman Memorial VA Hospital, Columbia, MO, USA; Department of Medicine-Gastroenterology and Hepatology, Columbia, MO, USA.
Sree V ChintapalliArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Umesh D WankhadeArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Kartik ShankarArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Dustie N ButteigerDuPont Nutrition & Health, St. Louis, MO, USA.
Elaine S KrulDuPont Nutrition & Health, St. Louis, MO, USA.
John P ThyfaultDepartment of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA; Kansas City VA Medical Center, Kansas City, MO, USA.
R Scott RectorDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, USA; Harry S Truman Memorial VA Hospital, Columbia, MO, USA; Department of Medicine-Gastroenterology and Hepatology, Columbia, MO, USA. Electronic address: rectors@health.missouri.edu.
Harry S. Truman Memorial Veterans' Hospital · USArkansas Children's Nutrition Center · USDuPont (United States) · USKansas City VA Medical Center · USUniversity of Arkansas for Medical Sciences · US

Funding

Aerobic fitness, mitochondrial dysfunction, and fatty liver diseaseR01DK088940 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI THYFAULT, JOHN P · 2011 to 2015
$1.5M
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosisI01BX002567 · VA · KANSAS CITY VA MEDICAL CENTER · PI THYFAULT, JOHN P · 2015 to 2025
–
Hepatic eNOS in the regulation of NASHI01BX003271 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI RANDY SCOTT RECTOR · 2017 to 2026
–
Evaluation of robot assisted neuro-rehabilitationI01RX000123 · VA · BALTIMORE VA MEDICAL CENTER · PI BEVER, CHRISTOPHER T · 2009 to 2014
–
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 DiabetesIK2BX001299 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI RECTOR, RANDY SCOTT · 2011 to 2015
–
BLRD VA I01 BX002567BLRD VA I01 BX003271BLRD VA IK2 BX001299NIDDK NIH HHS R01 DK088940RRD VA I01 RX000123
6 · The paper itself

Abstract

Soy protein is effective at preventing hepatic steatosis; however, the mechanisms are poorly understood. We tested the hypothesis that soy vs. dairy protein-based diet would alter microbiota and attenuate hepatic steatosis in hyperphagic Otsuka Long-Evans Tokushima fatty (OLETF) rats. Male OLETF rats were randomized to "Western" diets containing milk protein isolate (MPI), soy protein isolate (SPI) or 50:50 MPI/SPI (MS) (n=9-10/group; 21% kcal protein) for 16 weeks. SPI attenuated (P<.05) fat mass and percent fat by ~10% compared with MS, but not compared with MPI. Serum thiobarbituric acid reactive substance and total and low-density lipoprotein cholesterol concentrations were lower (P<.05) with dietary SPI vs. MPI and MS. Histological hepatic steatosis was lower (P<.05) in SPI compared with MPI or MS. Lipidomic analyses revealed reductions (P<.05) in hepatic diacylglycerols but not triacylglycerols in SPI compared with MPI, which was associated with lower hepatic de novo lipogenesis (ACC, FAS and SCD-1 protein content, and hepatic 16:1 n-7 and 18:1 n-7 PUFA concentrations) (P<.05) compared with MPI and MS; however, MPI displayed elevated hepatic mitochondrial function compared with SPI and MS. Fecal bacterial 16S rRNA analysis revealed SPI-intake elicited increases (P<.05) in Lactobacillus and decreases (P<.05) in Blautia and Lachnospiraceae suggesting decreases in fecal secondary bile acids in SPI rats. SPI and MS exhibited greater (P<.05) hepatic Fxr, Fgfr4, Hnf4a, HmgCoA reductase and synthase mRNA expression compared with MPI. Overall, dietary SPI compared with MPI decreased hepatic steatosis and diacylglycerols, changed microbiota populations and altered bile acid signaling and cholesterol homeostasis in a rodent model of obesity.

Indexed as

Diet, WesternGastrointestinal MicrobiomeAnimalsBile Acids and SaltsFatty AcidsFecesGene ExpressionIleumLiverMaleMilk ProteinsMitochondria, LiverNon-alcoholic Fatty Liver DiseaseObesityOxidative StressRats, Inbred OLETFBile Acids and SaltsFatty AcidsMilk ProteinsSoybean ProteinsTriglyceridesBile acidsCholesterolLipid metabolismMicrobiotaNAFLDSoy protein

Identifiers

PMID28605664
PMCPMC5542587
OpenAlexW2618815655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.